Statista:The Rise of E-Cigarettes: Trends in Germany

Industry Insight by 2FIRSTS.ai
Aug.15.2024
Statista:The Rise of E-Cigarettes: Trends in Germany
Germany sees a decline in traditional cigarette smoking and a surge in e-cigarette use, with sales projected to continue growing.

According to a report from T3n on August 14, in recent years, the number of people smoking traditional cigarettes in Germany has gradually decreased, while the use of e-cigarettes has significantly increased.

Statista:The Rise of E-Cigarettes: Trends in Germany
Image source: Statista Market Insights


According to data from the e-cigarette trade association, sales reached approximately 600 million euros in 2022, with expectations for continued growth in 2023 and 2024. Unlike traditional tobacco cigarettes, the prices of e-cigarette liquid and pods have remained stable in recent years. In July 2024, the consumer price index for e-cigarette products was 105.2 points (based on 2020=100), while the index for tobacco was around 130.4 points during the same period.


According to data from Statista, e-cigarettes of various flavors are attracting young people. Approximately 18.6% of consumers are between the ages of 18 and 24. Among adults, the age group with the highest number of users is 25 to 34, accounting for 27.3%, followed by 35 to 44, at 22.2%. In older age groups, the proportion of e-cigarette users gradually decreases.


According to data from Statista Market Insights, ELFBAR holds approximately 55% of the e-cigarette market in Germany, due to its advantages in appearance and pricing. Its biggest competitors are the e-cigarette brands Vuse (31%) and Juul (7%).


According to reports, Statista is a global data platform headquartered in Germany, focusing on market and consumer data. Founded in 2007, it provides users with statistics on over 80,000 topics, covering more than 170 industries. These data come from over 22,500 sources, including market research reports, industry analysis, government data, and statistics from media and academic institutions.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
Reuters: The US FDA, under pressure from the White House, will complete its review of nicotine pouches such as ZYN, VELO, and on! by the end of December
Reuters: The US FDA, under pressure from the White House, will complete its review of nicotine pouches such as ZYN, VELO, and on! by the end of December
The U.S. FDA will launch a pilot program to accelerate reviews of nicotine pouch products from Philip Morris International, Altria, BAT’s Reynolds American, and Turning Point Brands, aiming to complete the process by December 2025. The move, driven by pressure from the Trump administration, seeks to address past multi-year approval delays. Nicotine pouches, the fastest-growing U.S. smoking alternative, are seen as lower-risk but raise youth appeal concerns.
Sep.08
Experts Make the Case for THR in Asia-Pacific, as Demand, Science, and Industry Drive Its Growth
Experts Make the Case for THR in Asia-Pacific, as Demand, Science, and Industry Drive Its Growth
At the inaugural AFN, Dr. Rohan Sequeira and Dr. Alex Wodak emphasized that THR offers a science-based approach to reduce smoking-related harm—not merely as an alternative to cessation. They urged policymakers across Asia to reassess tobacco control and include non-combustible products in public health strategies. This article outlines the scientific foundation of THR, its regional challenges, and growth momentum.2Firsts provided in-depth coverage of the forum.
Sep.09
Ripon Shop Fined After Selling Illegal High-Nicotine Vapes Equal to “50 Packs”in the UK
Ripon Shop Fined After Selling Illegal High-Nicotine Vapes Equal to “50 Packs”in the UK
A Ripon retailer and its director were prosecuted after trading standards officers uncovered hundreds of illegal disposable vapes with nicotine volumes far above U.K. limits. Barlick Megatronic Mobiles Ltd (trading as Phonefix) and director Humayoun Khan pleaded guilty at York Magistrates’ Court on Sept. 4, 2025. Officers seized 654 illegal vapes in February 2024, then bought another unlawful device during an October follow-up. While the dissolved company avoided a corporate penalty, Khan was fi
Sep.08
Spanish Anti-Tobacco Group Urges 10-Year “Cooling-Off” Ban on Ex-Officials Working for Tobacco Industry
Spanish Anti-Tobacco Group Urges 10-Year “Cooling-Off” Ban on Ex-Officials Working for Tobacco Industry
Spanish advocacy group Nofumadores.org has called for urgent reforms to Spain’s conflict-of-interest rules to bar politicians and senior civil servants from taking jobs in the tobacco industry for 10 years after leaving office. The appeal follows a series of hires by Philip Morris, Japan Tobacco International (JTI) and distributor Logista that the group says risk undermining ongoing anti-tobacco legislation. The Health Ministry, led by Mónica García, aims to expand smoke-free spaces, raise tobac
Sep.08
2Firsts Feature | The “Pink Tax” in Vaping: How Women-Centric Design and Pricing Are Recasting the Competitive Landscape
2Firsts Feature | The “Pink Tax” in Vaping: How Women-Centric Design and Pricing Are Recasting the Competitive Landscape
Overseas e-cig brands are embracing “for her” designs, turning devices into fashion accessories. 2Firsts notes a new “pink tax” emerging through design and pricing, reflecting shifting gender and branding strategies.
Oct.20